恶性组织细胞增多症。对依托泊苷（VP - 16 - 213）和阿糖胞苷的反应。
Malignant histiocytosis. Response to VP-16-213 and cytosine arabinoside.
作者信息
Vera R, Bertino J R, Cadman E, Waldron J A
出版信息
Cancer. 1984 Sep 15;54(6):991-3. doi: 10.1002/1097-0142(19840915)54:6<991::aid-cncr2820540608>3.0.co;2-r.
Abstract
A patient with malignant histiocytosis who relapsed after receiving an Adriamycin (doxorubicin)-containing combination and radiation therapy subsequently had a complete remission on VP-16-213 and cytosine arabinoside. She remains free of disease 32 months after achieving a complete remission. VP-16-213 and cytosine arabinoside (Ara-C) deserve further evaluation in the treatment of this neoplasm.
摘要
一名恶性组织细胞增多症患者在接受含阿霉素（多柔比星）联合化疗及放疗后复发，随后使用依托泊苷（VP - 16 - 213）和阿糖胞苷治疗获得完全缓解。在完全缓解32个月后，她仍无疾病复发。依托泊苷（VP - 16 - 213）和阿糖胞苷（Ara - C）在该肿瘤治疗中值得进一步评估。
Zotero 插件